Skip to Main Content

Paper Details

Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana.
Pharmacogenomics J
11
2018
2B6, 516G, CNS, CYP, CYP polymorphisms, CYP2B, CYP2B6, CYP2B6 516G, EFV, HIV, HIV-infected, SNPs, cytochrome P450, efavirenz, patients, rs2279345, rs28399433, rs28399499, rs4802101, rs4803417, rs61663607
Author NameAffiliation
Marijana VujkovicCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine
Scarlett L BellamyDornsife School of Public Health, Drexel University
Athena F ZuppaThe Children's Hospital of Philadelphia
Andrew P SteenhoffThe Children's Hospital of Philadelphia
Mosepele MosepeleUniversity of Botswana
Brian L Strom
Richard AplencThe Children's Hospital of Philadelphia
Richard AplencThe Children's Hospital of Philadelphia
Robert GrossCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine
Robert GrossUniversity of Pennsylvania Perelman School of Medicine
  • 1 - 10

Datasets

Release 1.2